<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>DUB</title>
  <link rel="stylesheet" href="/style.css">
  <link rel="stylesheet" href="/notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="/index.html">
    <div class="home-navigation">
      M
    </div>
  </a>

  <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="/index.html">Home</a>
      </li>
      <li class="menu__item">
        <a class="menu__link" href="#0">About</a>
      </li>
      
     
      

      <li class="menu__item">
        <a class="menu__link" href="#0">Projects</a>
        <ul class="submenu">
          <li class="menu__item">
            <a class="menu__link" href="#0">Surgery</a>
          </li>
          <li class="menu__item">
            <a class="menu__link" href="#0">Pediatrics</a>
          </li>
        </ul>
      </li>
    </ul>
  </nav>
  
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="">Contribute here</a> </span>
    </div>

    <h1>Dysfunctional uterine bleeding</h1>
  
    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <label class="trigger outline">
        <input type="checkbox" class="checkbox checkbox--red" /> Show/hide outline
        <div class="msg">
         <ol>
            <li><a href="#header-1">Introduction</a></li>
            <li><a href="#header-2">Types/classification</a></li>
            <li><a href="">Clinical presentation</a></li>
            <li><a href="">Differential diagnosis</a></li>
            <li><a href="">Investigations</a></li>
            <li><a href="">Treatments</a></li>
         </ol>
        </div>
      </label>
        <section id='header-1'>
            <header>
            <h2>     
                <a aria-hidden='true' href='#header-1'>Introduction</a>
            </h2>
            </header>
            <div class='body'>
                <p>Dysfunctional uterine bleeding (DUB) is classically defined as abnormal (excessively heavy, scanty, prolonged, frequent or infrequent) bleeding of uterine origin that is not caused by pregnancy or recognizable pelvic or systemic disease.</p>
                <p>Up to 20% of women will experience irregular cycles in their lifetimes.</p>
                <p>It is a <span class="underlined--offset">diagnosis of exclusion</span> i.e. it is only diagnosed after the most probable causes have been ruled out by appropriate investigations. Causes such as: </p>
                <ul>
                    <li>Pregnancy</li>
                    <li>Medications </li>
                    <li>Iatrogenic causes </li>
                    <li>Genital tract pathology </li>
                    <li>Malignancy</li>
                    <li>Systemic diseases e.g. bleeding disorders</li>

                </ul>
        </section>
        <section id='header-2'>
            <header>
            <h2>
                <a aria-hidden='true' href='#header-2'>Types/classification</a>
            </h2>
            </header>
            <div class='body'>
                <ol>
                    <li>Anovulatory</li>
                    <li>Ovulatory</li>
                </ol>
                <p>Approximately <span class="special-text-3">90% </span> of dysfunctional uterine bleeding cases result from anovulation, and <span class="special-text-3">10% </span> of cases occur with ovulatory cycles.</p>
                <section id='heading-2-1'>
                    <header>
                    <h3>
                        <a aria-hidden href='#heading-2-1'>Anovulatory DUB</a>
                    </h3>
                    </header>
                    <div class='body'>
                        <p>Usually results from <span class="underlined--offset">disordered functioning of the hypothalamic-pituitary-ovarian (HPO) axis</span>.</p>
                        <p>Occurs most often in <span class="underlined--offset">women at the extreme ends of their reproductive lifetime</span>. </p>
                        <p>Both <span class="special-text">perimenarchal</span> and <span class="special-text">perimenopausal</span> women have several anovulatory cycles per year, it is therefore a common problem in adolescent females as well as elderly women.</p>
                        <p>Other causes/risk factors for anovulatory uterine bleeding include- </p>
                        <ul>
                            <li>Excessive exercise</li>
                            <li>Emotional stress</li>
                            <li>Eating disorders (bulimia and anorexia)</li>
                            <li>Obesity</li>
                            <li>Polycystic ovarian syndrome (PCOS)</li>
                            <li>Hyperprolactinemia </li>
                            <li>Thyroid disease</li>
                        </ul>
                        <p>Most cannot be classified as DUB, some are gray areas.</p>
                        <figure>
                            <img src="" alt="">
                            <figcaption>fig. I. Pathway of action of hormones for normal menstrual function.</figcaption>
                        </figure>
                        <section id='heading-2-1-1'>
                        <header>
                        <h4>
                            <a aria-hidden href='#heading-2-1-1'>Hypothalamic-Pituitary-Ovarian (HPO) axis</a>
                        </h4>
                        </header>
                        <div class='body'>
                            <p>GnRH is released from the hypothalamus <span class="underlined--offset">in pulses</span> which vary depending on the phase in the menstrual cycle.</p>
                            <p>GnRH pulse frequency is approximately <span class="underlined--offset">once per 90 min in the follicular phase</span>.</p>
                            <p>The pulses are <span class="underlined--offset">less frequent in the luteal phase</span>, occurring approximately <span class="underlined--offset">once in 4 h</span>.</p>
                            <p>GnRH acts on the anterior pituitary through the <span class="special-text">hypothalamohypophyseal portal system</span> to cause release of the gonadotropins - LH and FSH. These in turn act on the ovary to cause release of estrogen and progesterone.</p>
                            <p>Disorders that slow GnRH pulsatility, such as anorexia nervosa, result in failure of secretion of pituitary gonadotropins (LH and FSH) and a state of hypogonadal hypogonadism with failure of follicular development and amenorrhea.</p>
                            <p>Less severe reductions in GnRH pulse amplitude and frequency result in diminished FSH and LH with some follicular stimulation but not enough to result in ovulation but estradiol is secreted. This may occur in stress, hyperprolactinemia, excessive exercise or may be idiopathic.</p>
                            <p>An understanding of the normal cyclic fluctuations of the 2 gonadotropins (i.e., luteinizing hormone [LH], follicle-stimulating hormone [FSH]) and the primary female reproductive hormones (i.e., estrogen, progesterone) helps clarify the derangements associated with anovulation.</p>
                        </div>
                        </section>
                        <section id='heading-2-1-2'>
                            <header>
                            <h4>
                                <a aria-hidden href='#heading-2-1-2'>Pathophysiology of Anovulatory DUB</a>
                            </h4>
                            </header>
                            <div class='body'>
                                <p>With anovulation, estrogen levels rise as usual in the early phase of the cycle,  a corpus luteum never forms and progesterone is not produced.</p>
                                <p> The endometrium moves into a hyperproliferative state, ultimately outgrowing its estrogen supply. </p>
                                <p>This leads to irregular sloughing of the endometrium and excessive bleeding from spiral arteries that have not undergone physiological senescence.</p>
                                <figure>
                                    <img src="" alt="">
                                    <figcaption>fig. II. Dysfunctional uterine bleeding.</figcaption>
                                </figure>
                            </div>
                        </section>
                </section>
                <section id='heading-2-2'>
                    <header>
                    <h3>
                        <a aria-hidden href='#heading-2-2'>Ovulatory DUB</a>
                    </h3>
                    </header>
                    <div class='body'>
                        <p>This type of bleeding occurs cyclically, and thought to originate from defects in the control mechanisms of menstruation.</p>
                        <p>Occurs in women of reproductive age.</p>
                        <p>Occurs less commonly.</p>
                        <section id='heading-2-2-1'>
                        <header>
                        <h4>
                            <a aria-hidden href='#heading-2-2-1'>Normal menstrual cycle</a>
                        </h4>
                        </header>
                        <div class='body'>
                            <p>The normal cycle is <span class="special-text-3">28-29 days</span> (range of <span class="special-text-3">21-35d</span>).</p>
                            <p>Normal menstrual flow lasts <span class="special-text-3">3-7days</span>.</p>
                            <p>Average total blood loss of <span class="special-text-3">25-69 mL</span>. Flow longer than <span class="special-text-3">7 days</span> and blood loss exceeding <span class="special-text-3">80 mL</span> is considered abnormal.</p>
                            <p>The normal cycle is characterized by sequential growth, maturation and eventual sloughing of the endometrial mucosa. </p>
                            <p>This is produced by the cyclic release of estrogen and progesterone from the ovary and is orchestrated by the HPO axis.</p>
                            <figure>
                                <img src="" alt="">
                                <figcaption>fig. III. The first 14 days of a typical 28-day menstrual cycle are characterized by rising FSH levels.</figcaption>
                            </figure>
                            <p>FSH stimulates ovarian follicle development and the subsequent production of estrogen, primarily estradiol.</p>
                            <p>The endometrium, under the influence of estrogen, undergoes proliferation.</p>

                            <figure>
                                <img src="" alt="">
                                <figcaption>fig. IV. The menstrual cycle.</figcaption>
                            </figure>
                            <p>LH levels abruptly peak on day 12 or 13 in positive response to rising estrogen level. The LH surge stimulates-</p>
                            <ul>
                                <li>Ovulation (on or about day 14), and </li>
                                <li>Conversion of the ovulatory follicle to corpus luteum, which is responsible for progesterone production.</li>
                            </ul>
                            
                            <figure>
                                <img src="" alt="">
                                <figcaption>fig. V. The menstrual cycle.</figcaption>
                            </figure>
                            <p>Under the influence of progesterone, the endometrium is converted to a secretory state in preparation for implantation if fertilization of the ovum should occur. Progesterone is produced only if ovulation occurs. </p>
                            <figure>
                                <img src="" alt="">
                                <figcaption>fig. VI. Gonadotropins and ovarian hormone pattern in normal menstrual cycle.</figcaption>
                            </figure>

                            <p>As LH levels drop (in the absence of fertilization, production of human chorionic gonadotropin [HCG] by the developing conceptus does not occur), the corpus luteum regresses, estrogen and progesterone levels plummet, and the endometrium deteriorates and is sloughed.</p>
                        </div>
                        </section>
                        <section id='heading-2-2-2'>
                            <header>
                            <h4>
                                <a aria-hidden href='#heading-2-2-2'>Pathophysiology of Ovulatory DUB</a>
                            </h4>
                            </header>
                            <div class='body'>
                                <p>Bleeding occurs cyclically.</p>
                                <p> There is an increased rate of blood loss resulting from vasodilatation of the vessels supplying the endometrium due to <span class="underlined--offset">decreased vascular tone</span>, and prostaglandins have been strongly implicated. </p>
                                <p>Therefore, these women lose blood at rates about 3 times faster than women with normal menses.</p>

                                <div class="tips-card">
                                    <p class="tips-card-subtitle">note</p>
                                    <h4 class="tips-card-title">
                                      Prostaglandins involved in menstruation
                                    </h4>
                                    <p class="tips-card-content">
                                      <ul>
                                        <li>PGF<sub>2Œ±</sub>: Vasoconstrictor and weak platelet aggregator.</li>
                                        <li>PGE<sub>2</sub>: Vasodilator and weak platelet anti-aggregator.</li>
                                        <li>PGD: Vasodilator and smooth muscle relaxant.</li>
                                        <li>PGI: Potent vasodilator and inhibitor of platelet aggregation.</li>
                                        <li>TXA<sub>2</sub>: Potent vasoconstrictor and platelet aggregator.</li>
                                      </ul>
                                        
                                    </p>
                                  </div>

                                <p>In women with normal blood flow the order of production of prostaglandins by the secretory endothelium is PGF2Œ±/PGE2/PGD.</p>
                                <p>Increased amount of PGI (prostacyclin) are produced in the myometrium of DUB patients due to increased production of endoperoxidases.</p>
                            </div>
                        </section>

                        <section id='heading-2-2-3'>
                            <header>
                            <h4>
                                <a aria-hidden href='#heading-2-2-3'>Common terminologies for abnormal menstruation</a>
                            </h4>
                            </header>
                            <div class='body'>
                                <p><span class="special-text">Menorrhagia</span>: heavy bleeding, including prolonged menstrual periods (bleeding that lasts more than 7 days), or excessive bleeding (blood loss of greater than 80 ml per period) during a normal length period.Regular cycles, prolonged duration, excessive flow.</p>
                                <p><span class="special-text">Metrorrhagia</span>: bleeding at irregular intervals, particularly between expected menstrual periods. Frequent and irregular cycles.</p>
                                <p><span class="special-text">Menometrorrhagia</span>: prolonged or excessive uterine bleeding that occurs irregularly and more frequently than normal. Irregular, prolonged, excessive. </p>
                                <p><span class="special-text">Hypermenorrhea</span>: a menstrual period with excessively heavy flow. Regular, normal duration, excessive flow.</p>
                                <p><span class="special-text">Polymenorrhea</span>: frequent regular cycles that is shorter than 21 days.</p>
                                <p><span class="special-text">Oligomenorrhea</span>: Infrequent cycles. Uterine bleeding at regular intervals from 35 days to 6 months.</p>
                                <p><span class="special-text">Amenorrhea</span>:  primary amenorrhea is the failure of menses to occur by age 16, in the presence of normal growth and secondary sexual characteristics. Secondary amenorrhea is the cessation of uterine bleeding in a post-menarchial girl or a reproductive-aged woman for > 6 months.</p>
                                <p><span class="special-text">Postmenopausal bleeding</span>:  uterine bleeding that occurs more than 1 year after the last menses in a woman with ovarian failure.</p>
                            </div>
                        </section>
                </section>
            </div>
        </section>
    </article>
    </article>

  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p>obgyn.materia</p>
          <span>üßò‚Äç‚ôÄÔ∏èüé∂üßò‚Äç‚ôÇÔ∏è </span>
        </div>
    </div>
  </footer>
</body>
</html>